Javier Crespo

Research:

Director of the Research group in Marqués de Valdecilla Research Institute (IDIVAL-HUMV) and Head of the clinical group associated with CIBERehd (GVC16 / EHD / 4), a multidisciplinary and transversal group that includes biologists, biotechnologists, chemists, nurses, and physicians among its components. Stable research lines in viral hepatitis (more than 25 years, I began with my doctoral thesis I read in 1993) and NASH (I started in 2001 with the publication of an original manuscript in Hepatology), I was a translational research study. I have experience in the management of multi-center projects. At this moment, our group is part of: the core of the Spanish Registry of Metabolic Associated Liver Disease (HEPAMET), the CIBERehd, the European consortium LITMUS for the study of NASH, we participate in more than 20 international clinical trials phase II and III. Moreover, we are running several research projects. I have broad experience in clinical and translational research. I have participated in more than 75 clinical trials phases I to III in HCV, and HBV. I have been granted with several R+D+I projects from public and private calls. I have given more than 100 presentations in national and international courses in liver diseases. I am an author in different guidelines and consensus in gastroenterology and hepatology. I have been a director and co-director in more than 20 national and international courses.

Research experience:

• Original articles published: More than 270
• Chapters of books or complete books: 50.
• Communications to congresses (national and international): More than 500.
• Conferences and invited papers (national and international): More than 120
• Clinical trials conducted: More than 75 trials phase I to III.
• Competitive funded research projects: 19
• Six-year research periods: 5
• PhD thesis supervised: 8
• PhD thesis ongoing: 8
• Total citations: >21.600

Academic records:

• Bachelor of Medicine. October 1985. Qualification: Outstanding.
• Degree of Doctor Medicine. October 1993. School of Medicine of the University of Cantabria. Extraordinary Doctorate Award.

Current and past positions:

• Head of the Gastroenterology and Hepatology Unit. University Hospital Marqués de Valdecilla.
• Head of the Digestive Diseases Research Group in the Marqués de Valdecilla Research Institute (IDIVAL).
• Professor of Medicine at the University of Cantabria.
• President of the National Commission of the Digestive Specialty (2014-2022)
• President of the Spanish Society of Digestive Diseases (SEPD) (2018-2022)

Other merits:

• Member of the Strategic Plan of the National Health System to tackle hepatitis C infection.
• National and international evaluator and reviewer for different international journals and research scholarship programs.
• Commendation of the Civil Health Order. 2016
• Best in Class Award 2014 - 2018. Best Digestive Service in Spain.
• Best in Class Award 2015 - 2019. Best Hepatitis C Care Service in Spain.